12 May 2022
EFPIA Japan

EFPIA Japan Patient Organization Support Program “PASE”
Call for entries for the fifth PASE AWARDS~ Theme: Activities led by patient organizations for realization of patients’ better medicaltreatment and lives under the New Normal ~TOKYO – 12 May 2022 – EFPIA Japan is pleased to announce that the fifth PASE AWARDS will
be implemented as part of its patient advocacy program, PASE (Patient Advocacy Support byEFPIA Japan). This year’s theme is “Activities led by patient organizations for realization ofpatients’ better medical treatment and lives under the New Normal.” EFPIA Japan now welcomes
entries from patient groups and will provide a grant of 500,000 yen to Grand Prize winners (up totwo organizations) and 150,000 yen to an Honor Award winner.
More than two years have passed since the outbreak of the COVID-19 pandemic. This impacts
our lives and forces us to change our lifestyles in many ways. In such a situation, patient groups
and individual patients have come to be required to adapt to new modes of lives, known as the“New Normal”.
This year for the fifth PASE AWARDS will call for activity plans of patient organizations toempower patients to have appropriate diagnosis, treatment and disease control while adapting to
new lifestyles and preventing COVID-19 as well as activity plans to achieve healthcare policies
that reflect patient voices under the New Normal. Activity plans for peer support and chatting
rooms are outside the scope of the PASE AWARD.
EFPIA Japan promotes patient advocacy activities in Japan and supports the development of abetter healthcare environment for patients by working to ensure that the voices of patients areappropriately reflected in the healthcare system.

EFPIA JapanTokyo Opera City Tower, 3-20-2, Nishi Shinjuku, Shinjuku-ku, Tokyo, Japan

Fifth PASE AWARD Application Guidelines
Theme: Activities led by patient organizations for realization of patients’ better medicaltreatment and lives under the New Normal
We will call for activity plans that can activate communication among patients and doctors
more via online/SNS, which can be an example of lifestyle adapting to the New Normal.
Moreover, an activity plan can be to support isolated patients/their families who may beleft behind online communication under a situation of less direct communication in person
but more increase of online communication. Such a plan can prevent patient/their families
from being isolated socially and aim at making society for patients who will be able to havea proper medical treatment and reflect patients’ voices to achieve healthcare policies.

Application guidelines
1. Qualification requirements:
1. A patient group working for patients in Japan
2. An officially registered non-profit organization, such as an incorporated association,foundation, NPO, etc.
3. A patient group with a clear mission
4. A concrete implementation plan for an activity utilizing the grant (including how thegrant will be used)
5. A willingness to disseminate the results of the activity utilizing the grant (permission
to post on EFPIA Japan’s website, notification and reporting on the patient advocacy
group’s own and other websites).
2.

Period of conducting activities subjected to the application to grants:
1. Conduct activities using the grant by the end of June 2023
2. Submit an activity report (two A4 pages) to the EFPIA Japan Secretariat by the endof October 2023

3. Requirements to the award-winning organizations:
Attend the online presentation award ceremony on EFPIA Day (scheduled to be held in
September 2022. (There may be media coverage.)
4. Use of grants:
Applicants shall use the grants for clear implementation plans. Applicants shall neither
providegrants by cash to a person nor use grants for management costs of their organizations.
5. Application method:
Please refer to the URL below for the application method and send the necessary
documents
totheEFPIAJapan
PASE AWARD
Secretariat(paseaward@cocoknots.co.jp) by email as a PDF file by July 8, 2022.
With respect to the application method, please refer to such the method uploaded to the PASE
AWARD page seen in the EFPIA website. http://www.efpia.jp/pase/index.html

EFPIA JapanTokyo Opera City Tower, 3-20-2, Nishi Shinjuku, Shinjuku-ku, Tokyo, Japan

About the EFPIA Japan Patient Organization Support Program “PASE”
EFPIA Japan works with patients to support opportunities and activities that address patientneeds and policy proposals. PASE (Patient Advocacy Support by EFPIA Japan) PASE AWARDS
was created by the EFPIA Japan in 2017 as a means to more directly carry out its patient-centricmission to support patient organizations and promote the development of patient advocacy inJapan.
For the fourth PASE AWARDS, having the theme of “Addressing the challenges of the COVID-19
pandemic and encouraging connected, supportive societies” held in 2021, selection was basedon four evaluation criteria: 1) a patient group with a clear mission and performance indicators; 2)past activities with concrete results that achieve the stated goals; 3) a specific implementation
plan for an activity utilizing the grant; and 4) a willingness to disseminate the results of the activity
utilizing the grant (permission to post on EFPIA Japan’s website, notification and reporting on thepatient advocacy group’s own and other websites). Among 15 organizations, two were selected
for the Grand Prize and three were selected for the Honor Award to receive a total of 1.45 million
yen in grants. For further details, please refer to the link below.
http://efpia.jp/link/211004_PressRelease_EFPIA_Japan_PASE_4th_PASE_AWARD.pdf
About EFPIA Japan (http://efpia.jp/)
Established in April 2002, EFPIA Japan represents 23 R&D-based European pharmaceuticalcompanies operating in Japan. In 2020, combined sales from the member companies accounted
for roughly 23% of the pharmaceutical market in Japan. The mission of EFPIA Japan is to“Contribute to healthcare and patients in Japan through the early introduction of innovative
medicines and vaccines”. EFPIA Japan aims to strengthen dialogue with decision-makers in orderto improve Japanese healthcare for all.
About EFPIA (European Federation of Pharmaceutical Industries and Associations)(http://www.efpia.eu)
EFPIA, EFPIA Japan’s partner organisation, is headquartered in Brussels and represents thepharmaceutical industry operating in Europe. Through its direct membership of 36 nationalassociations and 39 leading pharmaceutical companies, EFPIA provides the voice of companies
committed to researching, developing and bringing new medicines to improve health and qualityof life around the world.

EFPIA JapanTokyo Opera City Tower, 3-20-2, Nishi Shinjuku, Shinjuku-ku, Tokyo, Japan

Contacts:
Takafumi Saito
EFPIA Japan Public Relations Committee, person
in charge of PASE
Novartis Pharma K.K.
Toranomon Hills Mori tower
1-23-1 Toranomon, Minato-ku, Tokyo 105-6333
TEL: 080-3478-4217
E-mail: takafumi.saito@novartis.com

Naomi Sakai
EFPIA Japan Patient Committee, person in
charge of PASE
Nippon Boehringer Ingelheim Co., Ltd.
ThinkPark Tower
2-1-1 Osaki, Shinagawa-ku, Tokyo 141-6017
TEL: 03-6417-2489
E-mail: naomi.sakai@boehringer-ingelheim.com

EFPIA JapanTokyo Opera City Tower, 3-20-2, Nishi Shinjuku, Shinjuku-ku, Tokyo, Japan